Effect of Acute Phenylcapsaicin Intake on Trained Cross-Training Athletes (CROSSCAPS)

January 14, 2025 updated by: Lucas Jurado-Fasoli, Universidad de Granada

Effect of Acute Phenylcapsaicin Intake on Trained Cross-Training Athletes: a Randomized, Placebo-Controlled Crossover Study

The aim of this study is to investigate the effect of acute phenylcapsaicin intake during a cross-training session on perceived exertion, performance, and recovery in cross-training athletes.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Capsaicin appears to enhance athletic performance by reducing perceived effort, increasing mechanical performance (e.g., total volume load), and decreasing muscle damage. Given the close relationship between the metabolic and physiological responses of cross-training and supplementation with Phenylcapsaicin (PC), it could be expected that consuming capsaicin during cross-training would have a favorable impact on perceived effort, recovery, and performance.

25 women and 24 men trained in CrossFit consumed either Phenylcapsaicin (PC) or a placebo during a CrossFit class, which consisted of a 16-minute weightlifting segment and a 15-minute WOD. Both the Rating of Perceived Exertion (RPE) and the Perceived Recovery Status scale (RPS) were administered at the beginning of the session and at the end of each segment of the CrossFit session. DOMS was assessed using a visual analog scale at 24 and 48 hours after the CrossFit session.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tenerife, Spain
        • Universidad de la Laguna

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age: 18-35 years.
  • Body mass index: 18.5-30 kg/m2.
  • Ability to understand the instructions, objectives, and study protocol.
  • Minimum of 3 years of experience in crosstraining, with at least 6 hours of weekly training over the past 3 months.
  • Resident on the island of Tenerife.

Exclusion Criteria:

  • History of a significant adverse cardiovascular event, renal insufficiency, cirrhosis, eating disorder, weight control surgical intervention, or type 2 diabetes mellitus.
  • Any chronic pathology in which the intake of nutritional supplements, especially pungent components, is not recommended.
  • Any condition that, in the investigator's judgment, would impair the ability to participate in the study or represent a personal risk to the participant.
  • Use of medications that may affect the study results.
  • Unstable body weight for 3 months prior to the start of the study (> 4 kg loss or gain in weight).
  • Active tobacco abuse or illicit drug use, or history of treatment for alcohol abuse.
  • On a special diet or prescribed for other reasons (e.g., celiac disease).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Phenylcapsaicin
2.5 mg of Phenylcapsaicin
2.5mg of Phenylcapsaicin
Placebo Comparator: Placebo
Preparation of colorants, sweeteners, aromas, and acidulants
Placebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance
Time Frame: 60min
Performance measured through the countermovement jump
60min
Performance
Time Frame: 60min
Deep squat test at 70% of repetition maximum
60min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate
Time Frame: 60min
Heart rate will be measured with the Polar H10 heart rate monitor
60min
Subjective fatigue throughe the RPE scale
Time Frame: 60min
Rate of perceived exertion scale
60min
Recovery
Time Frame: 60min
Perceived Recovery Status Scale (RPS)
60min
Delayed-onset muscle soreness (DOMS)
Time Frame: 60min
Delayed-onset muscle soreness (DOMS) scale (0-10 arbitrary units)
60min
Capillar lactate levels
Time Frame: 60min
Capillar lactate levels
60min
Performance: Weight used in the crosstraining session
Time Frame: 60min
Weight used in the crosstraining session
60min
Performance: Time performed in the crosstraining session
Time Frame: 60min
Time performed in the crosstraining session
60min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 2, 2024

Primary Completion (Estimated)

February 28, 2025

Study Completion (Estimated)

February 28, 2025

Study Registration Dates

First Submitted

January 14, 2025

First Submitted That Met QC Criteria

January 14, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 14, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CROSSCAPS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Performance

Clinical Trials on Placebo

Subscribe